TNF and rheumatic disorder: Some recent studies have suggested a cardiovascular protective role of anti-TNF-α agents in patients with rheumatic diseases (Lee et al., 2018; Ntusi et al., 2018; Vegh et al., 2020), which may be at least partially explained by the platelet-suppressing role of anti-TNF-α agents.